Morningside Group

by in

Entry	Author	Date	Location
Advanced Cell Diagnostics Receives $12,000,000 Series B Financing	VentureDeal	11/01/12	San Francisco
Genocea Biosciences Secures $30,000,000 Series C Financing	VentureDeal	10/10/12	Boston
Natural Polymer International Lands $2,580,000 New Funding	VentureDeal	06/30/12	Texas
Synchroneuron Receives $6,000,000 Series A Round	VentureDeal	02/07/12	Boston
Atreaon and Arsenal Spinoff 480 Biomedical Nab Funds	Erin Kutz	10/26/11	Boston
Aduro BioTech Secures $19,250,000 Series B Funding Round	VentureDeal	04/20/11	San Francisco
Genocea Biosciences Obtains $35,000,000 Series B Funding Round	VentureDeal	01/03/11	Boston
Cylene Pharmaceuticals Lands $12,000,000 New Funding Round	VentureDeal	09/27/10	San Diego
BioScale Receives $25,000,000 New Round	VentureDeal	06/11/10	Boston
BioVex Garners $30,000,000 Series F Funding	VentureDeal	11/10/09	Boston
Advanced Cell Diagnostics Garners $5,400,000 Series A Funding	VentureDeal	09/02/09	San Francisco
Genocea Biosciences Receives $23,000,000 Series A Financing Round	VentureDeal	02/19/09	Boston
ViOptix Obtains $3,000,000 New Round	VentureDeal	12/31/08	San Francisco
Critical Biologics Corporation Obtains $1,500,000 Series A Funding	VentureDeal	08/22/08	Boston
ThingMagic Inc. Secures $9,500,000 New Round	VentureDeal	07/14/08	Boston
Page 1 of 1

Xconomy National